CRDF FY 2013 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$133M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$259,246-42.4% YoY

Gross Profit

-$3M-1242.9% margin

Operating Income

-$11M-4123.7% margin

Net Income

-$12M-4555.9% margin

EPS (Diluted)

$-50.09

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$27M

Total Liabilities

$7M

Stockholders' Equity

$20M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$259,246	$450,000	-42.4%
Gross Profit	-$3M	-$1M	-119.2%
Operating Income	-$11M	-$5M	-120.5%
Net Income	-$12M	-$12M	-2.1%